CompoAtlas

SKIN HAIR NAILS

Natural health product licensed in Canada

Licence holder
HOLDING AGD
NPN or DIN-HM
80111162
Status
Active licence
Licence date
5 July 2021
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Riboflavine

Source : Riboflavine

0.7 mgNot calculated
Agaricus blazei

Source : Corps fructifère

Potency : 15 % beta-glucan

10 mgNot calculated
Vitamine B6

Source : Pyridoxine

0.7 mgNot calculated
Myrciaria dubia

Source : Fruit

Potency : 50 % Vitamin C

30 mgNot calculated
Niacine

Source : Niacinamide

8 mgNot calculated
Sélénium

Source : Sélénite de sodium

18 mcgNot calculated
Zinc

Source : Gluconate de zinc

11 mgNot calculated
Panicum miliaceum

Source : Graine

100 mgNot calculated
Eruca sativa

Source : Feuille

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 240 mg

60 mgNot calculated
Ascophyllum nodosum

Source : En entier

Potency : 0.1 % Iodine

60 mgNot calculated
Vaccinium myrtillus

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 100 mg

20 mgNot calculated
Arctium lappa

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 80 mg

20 mgNot calculated
Biotine

Source : Biotine

30 mcgNot calculated
Agaricus blazei

Source : Corps fructifère

Potency : 30 % Polysaccharides

Not specifiedNot calculated

Non-medicinal ingredients

Hydroxypropyl méthylcellulose, Mannitol, Xylitol

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsuleminimum: 1 par jour ; maximum: 2 par jour

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of fungal polysaccharides with immunomodulating properties. A factor in the maintenance of good health and normal growth and development. Contributes to maintaining general health. Helps in connective tissue formation. Helps in energy metabolism and in tissue formation. Helps maintain healthy skin and connective tissue formation. Helps to form red blood cells. Helps to maintain healthy bones, hair, nail and/or skin. Helps to maintain healthy hair, nail, mucous membranes and/or skin. Helps to maintain normal function of the thyroid gland. Helps to maintain the body's ability to metabolize nutrients. Helps with immune function. Maintains healthy hair, skin and nails. Multi-vitamin supplement. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Supports good health. Vitamin supplement. Source of/ Provides antioxidants.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80111162

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vaccinium myrtillus
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

  • Arctium lappa
    Read the warning, when it applies and the studies cited

    Burdock - Arctium Lappa - Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Barnes et al. 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur.

    Health Canada monograph dated 19 December 2025

    BURDOCK - ARCTIUM LAPPA - Topical

    Cautions and warnings

    For external use only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Barnes 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid contact with eyes and mucous membranes. If contact occurs, rinse thoroughly with water.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line